News & Updates

$Tocilizumab an effective substitute to anti-TNF agents in refractory Behçet disease$

Tocilizumab an effective substitute to anti-TNF agents in refractory Behçet disease

10 Jul 2023

Tocilizumab (TCZ) may be used as an alternative treatment to antitumour necrosis factor (anti-TNF) agents for patients with Behçet disease (BD)-related uveitis and neurological manifestations, a recent study has shown.

Tocilizumab an effective substitute to anti-TNF agents in refractory Behçet disease

10 Jul 2023

Certain drugs, antinuclear antibodies linked to GI dysfunction in SSc

10 Jul 2023

A phenome-wide association study (pheWAS) has found known and potentially new risk factors for gastrointestinal (GI) dysfunction in systemic sclerosis (SSc), which include drug classes such as opioid, antimuscarinic, and endothelin receptor antagonist, and antinuclear antibodies (ANAs) subgroup.

Certain drugs, antinuclear antibodies linked to GI dysfunction in SSc

10 Jul 2023

Smoking ups prevalence of hip involvement in ankylosing spondylitis

09 Jul 2023

Cigarette smoking is independently associated with a higher prevalence of hip joint involvement in ankylosing spondylitis (AS), suggests a study.

Smoking ups prevalence of hip involvement in ankylosing spondylitis

09 Jul 2023

Is it safe to use biologic drugs in pregnancy?

05 Jul 2023 by

Among the biologic drugs used during pregnancy, the most common is tumour necrosis factor-α antagonist (etanercept-infliximab-adalimumab), results of a clinical review have shown.

Is it safe to use biologic drugs in pregnancy?

05 Jul 2023

Real-world data back CV safety of JAK inhibitors

28 Jun 2023 by

Two real-world studies presented at EULAR 2023 reflected the cardiovascular (CV) safety of Janus kinase inhibitors (JAKi*) in patients with rheumatoid arthritis (RA).

Real-world data back CV safety of JAK inhibitors

28 Jun 2023

$Uricase-based combo therapy promising for refractory gout$

Uricase-based combo therapy promising for refractory gout

28 Jun 2023 by

Half of gout patients receiving novel uricase analogue infusions, along with a proprietary rapamycin formulation, got their serum urate controlled in two phase III studies presented at EULAR 2023.

Uricase-based combo therapy promising for refractory gout

28 Jun 2023

SGLT2 inhibitors score big, this time in gout

22 Jun 2023 by

Patients initiated on gliflozins or flozins – also called sodium-glucose co-transporter 2 (SGLT2) inhibitors – for type 2 diabetes (T2D) who were previously on metformin had reductions in the incidents of gout of up to 60 percent compared with other second-line agents in a recent study.

SGLT2 inhibitors score big, this time in gout

22 Jun 2023

Novel drug STRIDES in the right direction for knee OA

21 Jun 2023 by

In the phase III STRIDES X-Ray Extension study, additional doses of the investigational CLK/DYRK inhibitor lorecivivint delivered favourable outcomes for individuals with advanced knee osteoarthritis (OA).

Novel drug STRIDES in the right direction for knee OA

21 Jun 2023

Dazodalibep reduces Sjögren’s syndrome-related symptoms

21 Jun 2023 by

Treatment with dazodalibep, a novel nonantibody fusion protein that acts as an antagonist of CD40 ligand, significantly reduced symptom burden in adults with Sjögren’s syndrome, according to the ALISS trial presented at EULAR 2023.

Dazodalibep reduces Sjögren’s syndrome-related symptoms

21 Jun 2023

Romosozumab one-ups denosumab in boosting bone mineral density for chronic steroid users

20 Jun 2023 by

In the treatment of chronic glucocorticoid users with high fracture risk, romosozumab yields higher gains in spine bone mineral density (BMD) compared with denosumab, as shown in a pilot trial presented at EULAR 2023.

Romosozumab one-ups denosumab in boosting bone mineral density for chronic steroid users

20 Jun 2023

News & Updates

Filter by Specialty:

Specialty:

Tocilizumab an effective substitute to anti-TNF agents in refractory Behçet disease

Tocilizumab an effective substitute to anti-TNF agents in refractory Behçet disease

Certain drugs, antinuclear antibodies linked to GI dysfunction in SSc

Certain drugs, antinuclear antibodies linked to GI dysfunction in SSc

Smoking ups prevalence of hip involvement in ankylosing spondylitis

Smoking ups prevalence of hip involvement in ankylosing spondylitis

Is it safe to use biologic drugs in pregnancy?

Is it safe to use biologic drugs in pregnancy?

Real-world data back CV safety of JAK inhibitors

Real-world data back CV safety of JAK inhibitors

Uricase-based combo therapy promising for refractory gout

Uricase-based combo therapy promising for refractory gout

SGLT2 inhibitors score big, this time in gout

SGLT2 inhibitors score big, this time in gout

Novel drug STRIDES in the right direction for knee OA

Novel drug STRIDES in the right direction for knee OA

Dazodalibep reduces Sjögren’s syndrome-related symptoms

Dazodalibep reduces Sjögren’s syndrome-related symptoms

Romosozumab one-ups denosumab in boosting bone mineral density for chronic steroid users

Romosozumab one-ups denosumab in boosting bone mineral density for chronic steroid users